Drug Shortage Report for NABUMETONE

Last updated on 2020-09-03 History
Report ID 119621
Drug Identification Number 02238639
Brand name NABUMETONE
Common or Proper name Nabumetone
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) NABUMETONE
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BTL
ATC code M01AX
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-07
Estimated end date 2020-09-04
Actual end date 2020-09-02
Shortage status Resolved
Updated date 2020-09-03
Company comments
Health Canada comments
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-09-03 English Compare
v9 2020-09-02 French Compare
v8 2020-09-02 English Compare
v7 2020-08-18 French Compare
v6 2020-08-18 English Compare
v5 2020-07-23 French Compare
v4 2020-07-23 English Compare
v3 2020-07-08 English Compare
v2 2020-07-07 French Compare
v1 2020-07-07 English Compare